Results 111 to 120 of about 10,462 (212)

Trends in new psychoactive substance poisonings in the Netherlands: A 14‐year retrospective analysis (2012–2025)

Addiction, EarlyView.
Abstract Background and aims Data on the presence of new psychoactive substances (NPS) mainly originate from drug‐checking, law enforcement and wastewater analysis sources, while data on NPS poisonings are scarce. In Europe, the documented incidence rate of NPS poisonings is highest in the Netherlands.
Johanna J. Nugteren‐van Lonkhuyzen, Irma S. van den Hengel‐Koot, Claudine C. Hunault, Dylan W. de Lange, Antoinette J. H. P. van Riel, Laura Hondebrink   +5 more
wiley   +1 more source

UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Autism Spectrum Disorder. [PDF]

Neuropsychopharmacol Rep
Aggarwal A, Erridge S, Varadpande M, Clarke E, McLachlan K, Coomber R, Asghar M, Bhoskar U, Crews M, De Angelis A, Imran M, Kamal F, Korb L, Mwimba G, Sachdeva-Mohan S, Shaya G, Rucker JJ, Sodergren MH.   +17 more
europepmc   +1 more source

The Cannabis Research Image Database (CRESIDA): A standardized and validated image set for studying cannabis cue reactivity

Addiction, EarlyView.
Abstract Background and aims Cannabis cue reactivity paradigms are instrumental in studying the behavioral and neurocognitive mechanisms of cannabis use and cannabis use disorders; however, image sets used for cannabis cue reactivity paradigms vary between studies, and the lack of reliability and validity assessment hinders the quality of evidence they
Janna Cousijn, Emese Kroon, Chao Suo, Tom P. Freeman, Chandni Hindocha, Marianna Quinones‐Valera, Valentina Lorenzetti   +6 more
wiley   +1 more source

Characterizing the effect of short wavelengths on the floral flavonoid metabolome of medicinal cannabis using a comparative computational metabolomics workflow. [PDF]

Metabolomics
Contreras-Avilés W, Torres-Ortega LR, Heuvelink E, Marcelis LFM, van der Hooft JJJ, Kappers IF.   +5 more
europepmc   +1 more source

Beyond abstinence: Redefining success in cannabis use disorder treatment

Addiction, EarlyView.
Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin, Frances R. Levin, John Mariani, Christina A. Brezing   +3 more
wiley   +1 more source

Higher THC Concentration Medicinal Cannabis Products Efficacy and Safety Considerations: A Rapid Review. [PDF]

Drug Alcohol Rev
Graham M, Assefa D, Cong-Lem N, Nielsen S.   +3 more
europepmc   +1 more source

Cannabis use, affect and emotion regulation in daily life: A 3‐week experience sampling method study in people who smoke cannabis almost daily

Addiction, EarlyView.
Abstract Background and aims Although many people who use cannabis report mood‐enhancing effects, affective responses are thought to vary within and between individuals. This study examined the bidirectional associations between momentary affect and cannabis use and the potential moderating role of emotion regulation in this.
Ana Paula Gonçalves Donate, Janna Cousijn, Emese Kroon, Kristine Rømer Thomsen   +3 more
wiley   +1 more source

A retrospective analysis of voluntary adverse event reports to the TGA with higher THC medicinal cannabis products. [PDF]

Aust N Z J Psychiatry
Graham M, Tisdale C, Nielsen S.
europepmc   +1 more source

Overdose reversal through peer intervention: Findings from the naloxone prospective outcome research study (NalPORS) on the effectiveness of overdose response by people who use opioids in the United Kingdom and Sweden

Addiction, EarlyView.
Abstract Background/aims Take‐home naloxone (THN) programmes have been introduced in many European countries to provide non‐medically trained people who are likely to witness an opioid overdose, including people who use opioids, with a naloxone kit and training.
Nicola Metrebian, Teodora Dascal, Clare Mackie, Rose Tinch‐Taylor, Ben Carter, Joanne Neale, Mariana Gonzalez Utrilla, Ed Day, Joar Guterstam, Kirsten Horsburgh, Martin Kåberg, Mike Kelleher, Soraya Mayet, Josie Smith, Desiree Eide, Elin Holmén, Rebecca McDonald, Stephen Parkin, Henrik Thiesen, John Strang, NalPORS Research Team, Dean Acreman, Shabana Akhtar, Louise Aitken, Martin Anderson, James Cassidy, Sarah Cosgrove, Jo Grayer, Michelle Hughes, Louise Horn, Anika Miah, John Pratt   +31 more
wiley   +1 more source

Impact of mental health disorders on problematic substance use and effectiveness of brief intervention among young people in foster care

Addiction, EarlyView.
Abstract Background and aims Brief interventions delivered in healthcare settings represent a promising substance use prevention and early intervention strategy for youth in foster care, among whom early life adversity and resulting psychological sequalae increase risk for problematic substance use.
Courtney B. Dunn, Austin Blake, Katie Fox, Mary V. Greiner, Sarah J. Beal   +4 more
wiley   +1 more source